FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:154 January 14, 1999 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Recent studies have suggested that nifedipine is a safer, more effective treatment for preterm labor than the sympathomimetic agents routinely in use.^1,2 On the basis of these promising results, calcium-channel antagonists are increasingly prescribed for tocolysis. On the other hand, a case–control study of hypertensive patients found that patients who were taking calcium-channel antagonists had an increased risk of myocardial infarction,³ and a meta-analysis found a dose-dependent association between the use of nifedipine and the risk of death.⁴ These data, however, are not necessarily applicable to pregnant women who are being treated for preterm labor. We describe . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Roth, A., Elkayam, U. (2008). Acute myocardial infarction associated with pregnancy.. J Am Coll Cardiol 52: 171-180 [Abstract] [Full Text]